| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.33 | 1e-06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.29 | 2e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-05 |